全文获取类型
收费全文 | 1182篇 |
免费 | 114篇 |
国内免费 | 3篇 |
专业分类
耳鼻咽喉 | 7篇 |
儿科学 | 43篇 |
妇产科学 | 54篇 |
基础医学 | 240篇 |
口腔科学 | 11篇 |
临床医学 | 160篇 |
内科学 | 220篇 |
皮肤病学 | 34篇 |
神经病学 | 100篇 |
特种医学 | 11篇 |
外科学 | 97篇 |
综合类 | 8篇 |
一般理论 | 2篇 |
预防医学 | 120篇 |
眼科学 | 47篇 |
药学 | 70篇 |
肿瘤学 | 75篇 |
出版年
2024年 | 2篇 |
2023年 | 10篇 |
2022年 | 19篇 |
2021年 | 26篇 |
2020年 | 26篇 |
2019年 | 46篇 |
2018年 | 30篇 |
2017年 | 43篇 |
2016年 | 37篇 |
2015年 | 39篇 |
2014年 | 49篇 |
2013年 | 81篇 |
2012年 | 142篇 |
2011年 | 109篇 |
2010年 | 48篇 |
2009年 | 47篇 |
2008年 | 78篇 |
2007年 | 68篇 |
2006年 | 79篇 |
2005年 | 69篇 |
2004年 | 71篇 |
2003年 | 47篇 |
2002年 | 44篇 |
2001年 | 8篇 |
2000年 | 4篇 |
1999年 | 10篇 |
1998年 | 9篇 |
1997年 | 10篇 |
1996年 | 3篇 |
1995年 | 9篇 |
1994年 | 8篇 |
1993年 | 10篇 |
1992年 | 2篇 |
1989年 | 4篇 |
1988年 | 2篇 |
1987年 | 2篇 |
1985年 | 1篇 |
1983年 | 1篇 |
1982年 | 1篇 |
1976年 | 1篇 |
1975年 | 3篇 |
1973年 | 1篇 |
排序方式: 共有1299条查询结果,搜索用时 15 毫秒
61.
62.
Anneke Kuipers Mrta Balask Erika Ptervri Andreas Koller Susanne M. Brunner Gert N. Moll Barbara Kofler 《Neurotherapeutics》2021,18(4):2737
The regulatory (neuro)peptide galanin is widely distributed in the central and peripheral nervous systems, where it mediates its effects via three G protein-coupled receptors (GAL1-3R). Galanin has a vast diversity of biological functions, including modulation of feeding behavior. However, the clinical application of natural galanin is not practicable due to its rapid in vivo breakdown by peptidases and lack of receptor subtype specificity. Much effort has been put into the development of receptor-selective agonists and antagonists, and while receptor selectivity has been attained to some degree, most ligands show overlapping affinity. Therefore, we aimed to develop a novel ligand with specificity to a single galanin receptor subtype and increased stability. To achieve this, a lanthionine amino acid was enzymatically introduced into a galanin-related peptide. The residue’s subsequent cyclization created a conformational constraint which increased the peptide’s receptor specificity and proteolytic resistance. Further exchange of certain other amino acids resulted in a novel methyllanthionine-stabilized galanin receptor agonist, a G1pE-T3N-S6A-G12A-methyllanthionine[13–16]-galanin-(1–17) variant, termed M89b. M89b has exclusive specificity for GAL2R and a prolonged half-life in serum. Intranasal application of M89b to unfasted rats significantly reduced acute 24 h food intake inducing a drop in body weight. Combined administration of M89b and M871, a selective GAL2R antagonist, abolished the anorexigenic effect of M89b, indicating that the effect of M89b on food intake is indeed mediated by GAL2R. This is the first demonstration of in vivo activity of an intranasally administered lanthipeptide. Consequently, M89b is a promising candidate for clinical application as a galanin-related peptide-based therapeutic.Supplementary InformationThe online version contains supplementary material available at 10.1007/s13311-021-01155-x. 相似文献
63.
64.
Ingrid A.W. van Rijsingen Eloisa Arbustini Perry M. Elliott Jens Mogensen Johanna F. Hermans-van Ast Anneke J. van der Kooi J. Peter van Tintelen Maarten P. van den Berg Andrea Pilotto Michele Pasotti Sharon Jenkins Camilla Rowland Uzma Aslam Arthur A.M. Wilde Andreas Perrot Sabine Pankuweit Aeilko H. Zwinderman Philippe Charron Yigal M. Pinto 《Journal of the American College of Cardiology》2012
65.
Marka van Blitterswijk Michael A. van Es Max Koppers Wouter van Rheenen Jelena Medic Helenius J. Schelhaas Anneke J. van der Kooi Marianne de Visser Jan H. Veldink Leonard H. van den Berg 《Neurobiology of aging》2012
Previously, we have reported amyotrophic lateral sclerosis (ALS) families with multiple mutations in major ALS-associated genes. These findings provided evidence for an oligogenic basis of ALS. In our present study, we screened a cohort of 755 sporadic ALS patients, 111 familial ALS patients (97 families), and 765 control subjects of Dutch descent for mutations in vesicle-associated membrane protein B (VAPB). We have identified 1 novel VAPB mutation (p.V234I) in a familial ALS patient known to have a chromosome 9 open reading frame 72 (C9orf72) repeat expansion. This p.V234I mutation was absent in control subjects, located in a region with high evolutionary conservation, and predicted to have damaging effects. Taken together, these findings provide additional evidence for an oligogenic basis of ALS. 相似文献
66.
Daniëlle van Stein Erik A. Beckers Kees Sintnicolaas Leendert Porcelijn Fikreta Danovic Jacques A. Wollersheim Anneke Brand Dick J. van Rhenen 《Transfusion》2010,50(1):213-220
BACKGROUND: Transfusion-related acute lung injury (TRALI) is a serious, sometimes fatal complication of transfusion, attributed to white blood cell (WBC)-reactive antibodies present in the blood product. This study investigated incidence and etiology in the Netherlands.
STUDY DESIGN AND METHODS: From January 2005 through July 2007, all TRALI cases reported to the Sanquin Blood Banks were evaluated. Only cases meeting the Canadian Consensus Conference criteria for TRALI were included and investigated for patient, donor, and product characteristics. Patients and donors were screened for HLA Class I, HLA Class II, and granulocyte antibodies.
RESULTS: A total of 56 TRALI cases were reported of which 49 were completely evaluated. Seventy-eight percent of the patients needed monitoring or mechanical ventilation on the intensive care unit, 10 patients died. In 61% of cases large-volume plasma products were involved. WBC-reactive antibodies in donors were found in 73% of cases, with proven incompatibility in 21 of 44 (48%) investigated cases. Possible TRALI cases, as defined by the Canadian Consensus Conference, had significantly lower incompatibility rates compared to TRALI cases, 18% versus 58% (p = 0.036). In the 21 alloimmune cases, a total of 31 implicated donors were found, of which 26 were female, including 12 fresh-frozen plasma (FFP) products.
CONCLUSION: TRALI is the most serious transfusion complication in the Netherlands, causing severe morbidity and mortality. Antibodies were found in the majority of the cases, but causality with proven incompatibility could be established in 21 cases (48%). Female FFP products were involved in 57% of proven alloimmune cases and would theoretically be prevented using male FFP only. 相似文献
STUDY DESIGN AND METHODS: From January 2005 through July 2007, all TRALI cases reported to the Sanquin Blood Banks were evaluated. Only cases meeting the Canadian Consensus Conference criteria for TRALI were included and investigated for patient, donor, and product characteristics. Patients and donors were screened for HLA Class I, HLA Class II, and granulocyte antibodies.
RESULTS: A total of 56 TRALI cases were reported of which 49 were completely evaluated. Seventy-eight percent of the patients needed monitoring or mechanical ventilation on the intensive care unit, 10 patients died. In 61% of cases large-volume plasma products were involved. WBC-reactive antibodies in donors were found in 73% of cases, with proven incompatibility in 21 of 44 (48%) investigated cases. Possible TRALI cases, as defined by the Canadian Consensus Conference, had significantly lower incompatibility rates compared to TRALI cases, 18% versus 58% (p = 0.036). In the 21 alloimmune cases, a total of 31 implicated donors were found, of which 26 were female, including 12 fresh-frozen plasma (FFP) products.
CONCLUSION: TRALI is the most serious transfusion complication in the Netherlands, causing severe morbidity and mortality. Antibodies were found in the majority of the cases, but causality with proven incompatibility could be established in 21 cases (48%). Female FFP products were involved in 57% of proven alloimmune cases and would theoretically be prevented using male FFP only. 相似文献
67.
68.
Objective
This study examines the extent to which gender differences in use of services in three subcultures in Israel can be accounted for by the psychosocial differences between women and men, and by differences in the prevalence of common psychiatric disorders and levels of distress. 相似文献69.
70.
Neuromotor function and school performance in 7-year-old children born as high-risk preterm infants 总被引:3,自引:0,他引:3
Samsom JF de Groot L Cranendonk A Bezemer D Lafeber HN Fetter WP 《Journal of child neurology》2002,17(5):325-332
Neuromotor behavior was studied in 63 children at a mean age of 7 years. They were born at a gestational age less than 32 weeks and/or birthweight under 1500 g and were categorized according to their medical history in conformance with the Neonatal Medical Index (from category I to V, from few to serious complications). We included only children considered at high risk as categorized in III to V. The neuromotor behavior study focuses on different subcategories, such as hand function, quality of walking, posture, passive muscle tone, coordination, and diadochokinesia. Hand preference and/or lateralization, the presence of associated movements, and/or asymmetry were noted, as was school performance. Then gender, gestational age, birthweight, and dysmaturity were investigated as confounding factors. The outcome at 7 years was correlated with the Neonatal Medical Index and the neonatal brain ultrasonography classification. None of the children scored 100% on the combined subcategories. Nineteen children (30%) had an overall score between 75 and 99%. Significant relationships between all different subcategories were found. Lack of hand preference, poor lateralization, and male gender were related to poor overall outcome. Poor motor control was correlated to special schooling and education below age level. The Neonatal Medical Index proved to have a significant influence on total outcome and the subcategories at the age of 7 years, with the worst outcome in children formerly classified in category V. Neuromotor behavior at 7 years of age was not related to birthweight, gestational age, dysmaturity, and neonatal brain ultrasonography classification only. 相似文献